PD-1/PD-L1 inhibitor (eg. Tislelizumab): clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
3
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 4 1
Conditions being studied
| Condition | Trials |
|---|---|
| Extensive-stage Small Cell Lung Cancer (ES-SCLC) | 1 |
| Lung cancer | 1 |
| Squamous Non-Small Cell Lung Cancer sqNSCLC | 1 |
Recruiting trials involving PD-1/PD-L1 inhibitor (eg. Tislelizumab)
Common questions
How many recruiting trials involve PD-1/PD-L1 inhibitor (eg. Tislelizumab)?
1 recruiting trial across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.